Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Genetic variants of accessory proteins and G proteins in human genetic disease108
The role of immunophenotyping in common variable immunodeficiency: a narrative review92
Within-subject biological variation estimated using real-world data strategies (RWD): a systematic review81
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1964
Unlocking the link between haptoglobin polymorphism and noninfectious human diseases: insights and implications43
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications33
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review33
Molecular effects of ozone on amino acids and proteins, especially human hemoglobin and albumin, and the need to personalize ozone concentration in major ozone autohemotherapy29
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease28
Preterm labor tests: current status and future directions27
A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testing26
Genotype-phenotype correlation in the spectrum of frontotemporal dementia-parkinsonian syndromes and advanced diagnostic approaches22
G protein-coupled receptor (GPCR) pharmacogenomics22
Research progress of KL-6 in respiratory system diseases22
Omics-based novel strategies in the diagnosis of endometriosis21
Liquid biopsy for the management of NSCLC patients under osimertinib treatment21
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls21
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases19
The European Organisation of External Quality Assurance Providers in Laboratory Medicine (EQALM) Statement: guidelines for publishing about interlaboratory comparison studies (PubILC)19
Challenges of insulin-like growth factor-1 testing16
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath16
The elusive male microbiome: revealing the link between the genital microbiota and fertility. Critical review and future perspectives14
Current status in cellular-based therapies for prevention and treatment of COVID-1913
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications12
Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis12
The significance of antigen-antibody-binding avidity in clinical diagnosis12
Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome11
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future11
Design, optimization, and application of multiplex rRT-PCR in the detection of respiratory viruses11
Reference intervals: past, present, and future11
Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans11
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1910
Emerging applications of machine learning in genomic medicine and healthcare10
Correction10
Clinical utility of procalcitonin and its association with pathogenic microorganisms10
Lean and Six Sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory10
0.04612398147583